These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29773430)
21. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature. Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800 [TBL] [Abstract][Full Text] [Related]
22. FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study. Kostakoglu L; Goy A; Martinelli G; Caballero D; Crump M; Gaidano G; Baetz T; Buckstein R; Fine G; Fingerle-Rowson G; Berge C; Sahin D; Press O; Sehn L Leuk Lymphoma; 2017 Feb; 58(2):372-381. PubMed ID: 27339738 [TBL] [Abstract][Full Text] [Related]
24. Early Progression of Follicular Lymphoma: Biology and Treatment. Lipof JJ; Barr PM Hematol Oncol Clin North Am; 2020 Aug; 34(4):757-769. PubMed ID: 32586579 [TBL] [Abstract][Full Text] [Related]
25. Open questions in watchful waiting for follicular lymphoma. Sorigue M; Sancho JM; Ribera JM Br J Haematol; 2017 Nov; 179(4):679-681. PubMed ID: 27390920 [No Abstract] [Full Text] [Related]
26. Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma. Soumerai JD; Ni A; Alperovich A; Batlevi C; Bantilan KS; Fischer T; Copeland AR; Smith K; Ying Z; Younes A; Zelenetz AD Leuk Lymphoma; 2020 Dec; 61(12):2939-2946. PubMed ID: 32666852 [TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes. Corradini P; Ladetto M; Zallio F; Astolfi M; Rizzo E; Sametti S; Cuttica A; Rosato R; Farina L; Boccadoro M; Benedetti F; Pileri A; Tarella C J Clin Oncol; 2004 Apr; 22(8):1460-8. PubMed ID: 15084619 [TBL] [Abstract][Full Text] [Related]
28. Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients. Zinzani PL; Pellegrini C; Broccoli A; Casadei B; Argnani L; Pileri S Am J Hematol; 2013 Nov; 88(11):E273-6. PubMed ID: 23843267 [TBL] [Abstract][Full Text] [Related]
29. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group. Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G; J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481 [TBL] [Abstract][Full Text] [Related]
30. End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis. Pyo J; Won Kim K; Jacene HA; Sakellis CG; Brown JR; Van den Abbeele AD Clin Cancer Res; 2013 Dec; 19(23):6566-77. PubMed ID: 24052020 [TBL] [Abstract][Full Text] [Related]
31. Follicular lymphoma: have we made any progress? Horning SJ Ann Oncol; 2000; 11 Suppl 1():23-7. PubMed ID: 10707774 [TBL] [Abstract][Full Text] [Related]
32. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. Vidal L; Gafter-Gvili A; Leibovici L; Dreyling M; Ghielmini M; Hsu Schmitz SF; Cohen A; Shpilberg O J Natl Cancer Inst; 2009 Feb; 101(4):248-55. PubMed ID: 19211444 [TBL] [Abstract][Full Text] [Related]
38. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma. Jacobson CA; Freedman AS Curr Hematol Malig Rep; 2016 Jun; 11(3):218-23. PubMed ID: 26995595 [TBL] [Abstract][Full Text] [Related]
39. Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database. Procházka V; Papajík T; Janíková A; Belada D; Kozák T; Šálek D; Sýkorová A; Móciková H; Campr V; Dlouhá J; Langová K; Fürst T; Trněný M Leuk Lymphoma; 2017 Mar; 58(3):601-613. PubMed ID: 27666539 [TBL] [Abstract][Full Text] [Related]
40. A retrospective study on the management of patients with rituximab refractory follicular lymphoma. Solal-Céligny P; Leconte P; Bardet A; Hernandez J; Troussard X Br J Haematol; 2018 Jan; 180(2):217-223. PubMed ID: 29230799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]